Inhibition of LSD1 with bomedemstat sensitizes small cell lung cancer to immune checkpoint blockade and T cell killing. Hiatt JB, Sandborg H, Garrison SM, Arnold HU, et al. Clin Cancer Res 2022 Aug 3. pii: 707373. doi: 10.1158/1078-0432.CCR-22-1128.

Read + Share

Amedeo Smart

Independent Medical Education

Hiatt JB, Sandborg H, Garrison SM, Arnold HU, et al. Inhibition of LSD1 with bomedemstat sensitizes small cell lung cancer to immune checkpoint blockade and T cell killing. Clin Cancer Res 2022 Aug 3. pii: 707373. doi: 10.1158/1078-0432.CCR-22-1128.
PMID: 35920742